What is Australian Clinical Labs Limited (ACL) Stock Price?
The live share price and session change for Australian Clinical Labs Limited (ACL) are shown in the TradingView quote on this page.
ACL Stock Price, Valuation & Chart | Australian Clinical Labs Limited
ACL Historical price chart
ACL Key Stats
Fair Value
Disclaimer
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Market Capitalization522.25M
PE Ratio22.41
EPS0.12
Trading Volume716.70K
Today's High/Low2.83/2.76
Dividend Yield5.52
52 Week High/Low3.03/1.83
Shares Outstanding186.52M
ACL Financial Statement
ACL Analyst ratings
Neutral
Strong buy
0
Buy
2
Hold
6
Sell
0
Strong sell
0
Based on 8 analysts giving stock ratings to ACL in the past 3 months.
ACL Analysis & performance metrics
ACL Company profile
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular…
ACL Management team
Name
Position
Joe GeranCTO
National Marketing Director
Eleanor Padman B.A., FCIS
Company Secretary
Matthew CordingleyCFO
Chief Financial Officer
Sean JacksonCTO
Chief Information Officer
Anthony FriedliCOO
Chief Operating Officer
Associate Prof. Tony LandgrenCTO
National Medical Director & Chief Pathologist
Darren McKeeCEO
Chief Executive Officer of Victoria
Shae SeymourCEO
Chief Executive Officer of WA/SA/NT
Name
Position
Joe GeranCTO
National Marketing Director
Eleanor Padman B.A., FCIS
Company Secretary
Matthew CordingleyCFO
Chief Financial Officer
Sean JacksonCTO
Chief Information Officer
Anthony FriedliCOO
Chief Operating Officer
Associate Prof. Tony LandgrenCTO
National Medical Director & Chief Pathologist
Darren McKeeCEO
Chief Executive Officer of Victoria
Shae SeymourCEO
Chief Executive Officer of WA/SA/NT
Management Team
Joe GeranCTO
National Marketing Director
Eleanor Padman B.A., FCIS
Company Secretary
Matthew CordingleyCFO
Chief Financial Officer
Sean JacksonCTO
Chief Information Officer
Anthony FriedliCOO
Chief Operating Officer
Associate Prof. Tony LandgrenCTO
National Medical Director & Chief Pathologist
Darren McKeeCEO
Chief Executive Officer of Victoria
Shae SeymourCEO
Chief Executive Officer of WA/SA/NT
Management
Joe GeranCTO
National Marketing Director
Eleanor Padman B.A., FCIS
Company Secretary
Matthew CordingleyCFO
Chief Financial Officer
Sean JacksonCTO
Chief Information Officer
Anthony FriedliCOO
Chief Operating Officer
Associate Prof. Tony LandgrenCTO
National Medical Director & Chief Pathologist
Darren McKeeCEO
Chief Executive Officer of Victoria
Shae SeymourCEO
Chief Executive Officer of WA/SA/NT
Total 8 executives
ACL Frequently asked questions
Why is the Australian Clinical Labs Limited (ACL) stock price going up or down today?
The stock price of Australian Clinical Labs Limited (ACL) can change with earnings, company news, and overall market sentiment. Australian Clinical Labs Limited operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live TradingView quote on this page together with the chart and key stats.
Is the Australian Clinical Labs Limited stock expensive at its current price?
Whether Australian Clinical Labs Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ACL on this page is 22.41. EPS on this page is 0.12. Compare those figures with peers and growth expectations before deciding if the current Australian Clinical Labs Limited price is justified.
How has the stock price of Australian Clinical Labs Limited (ACL) performed historically?
Historical performance for Australian Clinical Labs Limited (ACL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ACL reacted to past earnings and market events.
Should I buy Australian Clinical Labs Limited (ACL) stock, at this price?
Buying Australian Clinical Labs Limited (ACL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.